Buy Endocyte Stock | ECYT Stock Price & Latest News | Public.com
ECYT

Endocyte

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Endocyte (ECYT) stock trends here

    About ECYT

    Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High
    1 Year Low
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app